Company news
Ondine Biomedical, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Steriwave shown to reduce resistant bacteria
October 18, 2023
Steriwave now in Canada's East Coast
October 13, 2023
Ondine to present poster at IP2023, Liverpool
October 10, 2023
Hospital to adopt Steriwave as standard-of-care
October 9, 2023
Burnaby Hospital deploys Steriwave
September 29, 2023
Half-year Report
September 25, 2023
Montreal Heart Institute pilots Steriwave
September 21, 2023
Steriwave proven effective against XDR bacteria
September 14, 2023
Steriwave evaluation at major heart institute
September 12, 2023
Ondine to present new AMR research at ICPIC Geneva
August 29, 2023
Issue of Equity and TVR
August 21, 2023
Ondine technology used in major Canadian hospital
August 7, 2023
Ondine commences first NHS Steriwave® pilot
August 1, 2023
Ondine receives impact award at IPA World Congress
July 17, 2023
Corporate Update
July 7, 2023
Photodisinfection cuts COVID in meat processing
June 22, 2023
Result of AGM
May 25, 2023
Annual Report for the Year Ended 31 December 2022
May 23, 2023
Full Year Results
May 10, 2023
Issue of Equity
May 3, 2023
Ondine reports successful food pathogen study
April 20, 2023
Ondine Phase 2 results presented at ECCMID 2023
April 18, 2023
Progress Update
April 17, 2023
Ondine food-safe photodisinfection update
April 5, 2023
Lux Vitae advocates Steriwave for COVID prevention
March 7, 2023
Ottawa hospital presents Steriwave study results
March 3, 2023
Grant of Share Options
February 22, 2023
Ondine's APDT reduces SARS-CoV-2 infectivity
January 31, 2023
TR-1: Notification of major holdings
January 17, 2023
Second Price Monitoring Extn
January 13, 2023
Appointment of Nominated Adviser
December 30, 2022
Steriwave receives regulatory approval in Mexico
December 12, 2022
Ondine receives funding for meat photodisinfection
December 5, 2022
Ondine reports full results from Phase 2 trial
December 2, 2022
Ondine appoints Spanish distributer for Steriwave
November 21, 2022
Food Processing Plant Sees Huge Reduction in Employee COVID-19 Rates After Using Ondine Biomedical’s Nasal Photodisinfection
November 8, 2022
Ondine cuts COVID-19 rate in food processing plant
November 7, 2022
PDMR Dealing
November 4, 2022
Ondine CTO receives Lifetime Achievement Award
October 31, 2022
Ondine presents new efficacy data against MRSA
October 19, 2022
Investor Presentation
October 11, 2022
Interim results for the six months to 30 June 2022
September 27, 2022
The Ottawa Hospital pilots nasal disinfection
September 23, 2022
New research presented on photodisinfection
September 20, 2022
Ondine's photodisinfection kills ESKAPE pathogens
September 7, 2022
Ondine reports successful US Phase 2 trial data
September 6, 2022
Nature reports Ondine therapy suppresses COVID-19
August 31, 2022
Ondine appoints RBC and Singer as joint brokers
August 16, 2022
Ondine completes US Phase II trial recruitment
August 8, 2022
Completion of Nominated Adviser due diligence
July 26, 2022
Calls
The 5 newest of 9 calls. Every call is listed under its year.
- Ondine Biomedical (LSE:OBI) — Investor Presentation of Phase 3 Topline Results
Sep 10, 2026
Transcript - Ondine Biomedical (LSE:OBI) — Results for the year ended 31 December 2025
Jun 4, 2026
Transcript - Ondine Biomedical (LSE:OBI) — Interim financial results for the period ended 30 June 2025
Sep 26, 2025
Transcript - Ondine Biomedical (LSE:OBI) — Audited results for the year ended 31 December 2024
May 15, 2025
Transcript - Ondine Biomedical (LSE:OBI) — Half Year Results
Sep 30, 2024
Transcript